In human, the expression of ASGR1 was observed to be significantly decreased in patients with NAFLD and NASH as well as in hepatic cirrhosis or in highly proliferative liver tumors [46, 59–61],. The gene discussed is ASGR1; the disease is metabolic dysfunction-associated steatotic liver disease.